AssesSment of the left atrial appendage morphoLogy in patients aAfter ischaeMic Stroke - the ASSAM study protocol

Jakub Baran1, Ilona Michałowska, Ilona Kowalik

  • 1Division of Clinical Electrophysiology, Department of Cardiology, Grochowski Hospital, Postgraduate Medical School, Warsaw, Poland, Poland. j.baran@sampi.pl.

Kardiologia Polska
|May 30, 2017
PubMed

Insights

Left atrial appendage morphology may be an unknown risk factor for stroke in atrial fibrillation (AF) patients. The ASSAM study investigates this link, comparing stroke patients with controls undergoing AF ablation.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Imaging

Background:

  • Atrial fibrillation (AF) is a major risk factor for ischemic stroke.
  • Current risk scores (e.g., CHA₂DS₂-VASc) identify known risk factors, but strokes still occur in anticoagulated patients.
  • This suggests the existence of "unknown" risk factors influencing stroke risk in AF.

Purpose of the Study:

  • To investigate left atrial appendage (LAA) morphology as a potential "unknown" risk factor for stroke in patients with atrial fibrillation.
  • To compare LAA morphology between patients who experienced ischemic stroke/TIA despite anticoagulation and AF patients without a history of stroke.

Main Methods:

  • The ASSAM study is a planned investigation.
  • It will enroll 100 patients who have experienced ischemic stroke or transient ischemic attack (TIA) while on anticoagulation.
  • A control group of 100 patients scheduled for AF ablation without prior stroke/TIA will also be included.

Main Results:

  • Results are pending as the ASSAM study is planned.
  • Analysis will focus on differences in LAA morphology between the two groups.
  • Correlation between specific LAA morphological features and stroke occurrence will be assessed.

Conclusions:

  • Left atrial appendage morphology may represent a significant, yet uncharacterized, risk factor for stroke in atrial fibrillation.
  • Identifying novel risk factors like LAA morphology could improve stroke risk stratification and prevention strategies in AF patients.
  • Further research is warranted to validate these findings and integrate LAA morphology into clinical decision-making.